Biodexa Pharmaceuticals Plc (BDRX)
2.41
-0.28
(-10.41%)
USD |
NASDAQ |
Nov 05, 16:00
2.47
+0.06
(+2.49%)
After-Hours: 06:50
Biodexa Pharmaceuticals SG&A Expense (TTM) : 5.629M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.629M |
| December 31, 2025 | 6.375M |
| June 30, 2025 | 5.354M |
| December 31, 2024 | 4.843M |
| June 30, 2024 | 5.143M |
| December 31, 2023 | 5.396M |
| June 30, 2023 | 5.988M |
| December 31, 2022 | 5.560M |
| June 30, 2022 | 4.182M |
| December 31, 2021 | 4.085M |
| June 30, 2021 | 4.946M |
| December 31, 2020 | 6.340M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.119M |
| December 31, 2019 | 5.320M |
| June 30, 2019 | 5.704M |
| December 31, 2018 | 5.868M |
| June 30, 2018 | 5.035M |
| December 31, 2017 | 5.673M |
| June 30, 2017 | 13.49M |
| December 31, 2016 | 25.47M |
| June 30, 2016 | 24.02M |
| December 31, 2015 | 13.07M |
| June 30, 2015 | 7.850M |
| June 30, 2014 | 3.123M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NuCana Plc | 7.064M |
| Mereo BioPharma Group Plc | 19.44M |
| BioNTech SE | 660.03M |
| Silence Therapeutics Plc | 21.27M |
| Autolus Therapeutics Plc | 152.92M |